\scalebox{0.75}{
\begin{tabular}{rlll}
\toprule
\multicolumn{1}{l}{\multirow{2}{*}{Patient Characteristics}} & \multicolumn{2}{c}{Time point} & \multirow{2}{*}{Laboratory Reference¶} \\ 
\cmidrule(l){2-3}
\multicolumn{1}{l}{} & Baseline & Follow-Up &  \\ 
\midrule
\multicolumn{1}{l}{N (Patients)} & 14 & 6 &  \\
\multicolumn{1}{l}{Age (Mean, Years):} & 56.2±15.3 & 47.0±19.0 & - \\
\multicolumn{1}{l}{Sex (male)} & 10 (71) & 3 (50) & - \\
\multicolumn{1}{l}{Body Mass Index (kg/m2):} & 28.4±5.9 & 27.3±7.3 & - \\
\multicolumn{1}{l}{APACHE2* Score at Critical Care Admission} & 20.4±5.9 & 19±6.6 & - \\
\multicolumn{1}{l}{Days Since Escalation to Level 2 or Level 3 Care**} & 9.1±8.8 & 11.7±11.0 & - \\
\multicolumn{1}{l}{Proportion of Patients Receiving Level 3 Care**} & 14 (100) & 6 (100) & - \\
\multicolumn{1}{l}{Primary Diagnosis on Admission} &  &  &  \\
Cardiac Arrest: & 1 (7) & 0 (0) & - \\
Type 1 Respiratory Failure† & 2 (14) & 2 (34) & - \\
Overdose & 1 (7) & 1 (17) & - \\
Toxic Shock Syndrome & 1 (7) & 1 (17) & - \\
Acute Biliary Disease‡ & 2 (14) & 1 (17) & - \\
Elective Igor-Lewis Oesophagectomy & 2 (14) & 0 (0) & - \\
Elective Whipple's Procedure & 1 (7) & 1 (17) & - \\
Elective Liver Transplantation & 3 (21) & 0 (0) & - \\
Elective Thoraco-aortic Aneurysm Repair & 1 (7) & 0 (0) & - \\
\multicolumn{1}{l}{\textbf{Indicators of Circulatory Function}} &  &  & - \\
Heart Rate (min-1) & 87.9±16.9 & 87.8±18.2 & - \\
Mean Arterial Pressure (mmHg) & 84.0±15.3 & 87.6±14.3 & - \\
24 Hour Fluid Balance (mL) & 460.4±1931.2 & -366.5±560.1 &  \\
Cumulative Fluid Balance Since Treatment Escalation (mL) & 5376.8±8461.5 & 6423±11896.1 & - \\
\multicolumn{1}{l}{\textbf{Predictors of Circulatory Function}} &  &  &  \\
Highest Lactate 24-Hours Preceding Sampling (mmol/L) & 1.54±1.00 & 0.98±0.30 & 0.5-1.6 \\
Creatinine Preceding Sampling (mmol/L) & 123.6±83.3 & 117.2±136.7 & 50-111 \\
Haemoglobin Preceding Sampling (g/L) & 95.2±20.1 & 92.7±21.3 & 115-180 \\
Haematocrit Preceding Sampling & 0.28±0.06 & 0.28±0.06 & 0.36-0.52 \\
Albumin Preceding Sampling (g/L) & 18.3±4.2 & 17.5±3.8 & 36-47 \\
\multicolumn{1}{l}{\textbf{Receipt of Organ Supportive Therapies}} &  &  &  \\
Receipt of Invasive Mechanical Ventilation & 4 (29) & 0 (0) & - \\
FiO2 Preceding Sampling & 31.0±19.5 & 23.8±5.6 & - \\
SaO2 Preceding Sampling & 96.7±2.2 & 98.0±1.4 & - \\
Receipt of Vasopressor Therapy & 3 (21) & 1 (17) & - \\
Receipt of Intra-Aortic Balloon Pump & 6 (43) & 2 (33) & - \\
Receipt of Renal Replacement Therapy & 0 (0) & 0 (0) & - \\
Receipt of Intravenous Sedation§ & 3 (21) & 1 (17) & - \\
Glasgow Coma Scale Preceding Sampling (Median, IQR) & 15, 3 & 15, 0 & - \\
\multicolumn{1}{l}{\textbf{Choroid measurements (Median, IQR)}} &  &  & - \\
Subfoveal choroid thickness ($\mu$m) & 249 (134) & 309 (150) & - \\
Area (mm$^2$) & 0.82 (0.62) & 1.15 (0.68) & - \\
Luminal area (mm$^2$) & 0.36 (0.35) & 0.60 (0.39) & - \\
\acrshort{CVI} & 0.44 (0.05) & 0.52 (0.07) & - \\
\multicolumn{1}{l}{\textbf{Suprachoroidal measurements (Median, IQR)}} &  &  &  \\
Subfoveal suprachoroidal thickness ($\mu$m) & 64 (34) & 48 (26) & - \\
Suprachoroidal area (mm$^2$) & 0.22 (0.16) & 0.21 (0.13) & - \\ 
\bottomrule
\end{tabular}
}
